Closing Bell Recap: Virpax Pharmaceuticals Inc (VRPX) Ends at 0.78, Reflecting a -65.94 Downturn

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

Virpax Pharmaceuticals Inc (NASDAQ: VRPX) closed the day trading at $0.78 down -65.94% from the previous closing price of $2.29. In other words, the price has decreased by -$65.94 from its previous closing price. On the day, 2.66 million shares were traded. VRPX stock price reached its highest trading level at $0.9211 during the session, while it also had its lowest trading level at $0.6811.


For a better understanding of VRPX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.72 and its Current Ratio is at 0.72.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRPX now has a Market Capitalization of 913559 and an Enterprise Value of -6459388.

Stock Price History:

Over the past 52 weeks, VRPX has reached a high of $11.77, while it has fallen to a 52-week low of $1.98. The 50-Day Moving Average of the stock is -77.82%, while the 200-Day Moving Average is calculated to be -85.37%.

Shares Statistics:

Over the past 3-months, VRPX traded about 28.66K shares per day on average, while over the past 10 days, VRPX traded about 294520 shares per day. A total of 1.17M shares are outstanding, with a floating share count of 0.87M. Insiders hold about 25.72% of the company’s shares, while institutions hold 0.20% stake in the company. Shares short for VRPX as of 1714435200 were 7941 with a Short Ratio of 0.28, compared to 1711584000 on 29830. Therefore, it implies a Short% of Shares Outstanding of 7941 and a Short% of Float of 0.91.

Earnings Estimates

On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$5. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$7.3 and -$7.3 for the fiscal current year, implying an average EPS of -$7.3. EPS for the following year is -$7.4, with 1.0 analysts recommending between -$7.4 and -$7.4.

Most Popular

[the_ad id="945"]